| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 461 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 339 | 2021 |
| Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination B Pozzetto, V Legros, S Djebali, V Barateau, N Guibert, M Villard, L Peyrot, ... Nature 600 (7890), 701-706, 2021 | 203 | 2021 |
| Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial X Roblin, G Boschetti, N Williet, S Nancey, H Marotte, A Berger, JM Phelip, ... Alimentary pharmacology & therapeutics 46 (2), 142-149, 2017 | 143 | 2017 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 135 | 2022 |
| Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting A Gutjahr, C Phelip, AL Coolen, C Monge, AS Boisgard, S Paul, B Verrier Vaccines 4 (4), 34, 2016 | 133 | 2016 |
| Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective … X Roblin, N Williet, G Boschetti, JM Phelip, E Del Tedesco, AE Berger, ... Gut 69 (7), 1206-1212, 2020 | 126 | 2020 |
| Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study W Yacoub, N Williet, L Pouillon, T Di‐Bernado, M De Carvalho Bittencourt, ... Alimentary pharmacology & therapeutics 47 (7), 906-912, 2018 | 107 | 2018 |
| BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology A Keat, N Barkham, A Bhalla, K Gaffney, H Marzo-Ortega, S Paul, ... Rheumatology 44 (7), 939-947, 2005 | 104 | 2005 |
| Triggering intracellular receptors for vaccine adjuvantation A Gutjahr, G Tiraby, E Perouzel, B Verrier, S Paul Trends in immunology 37 (9), 573-587, 2016 | 88 | 2016 |
| The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells A Gutjahr, L Papagno, F Nicoli, T Kanuma, N Kuse, MP Cabral-Piccin, ... JCI insight 4 (7), 2019 | 85 | 2019 |
| Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat G Courbon, M Rinaudo-Gaujous, V Blasco-Baque, I Auger, R Caire, ... Annals of the rheumatic diseases 78 (5), 594-599, 2019 | 79 | 2019 |
| Therapeutic drug monitoring of biologics during induction to prevent primary non-response MP Sparrow, K Papamichael, MG Ward, P Riviere, D Laharie, S Paul, ... Journal of Crohn's and Colitis 14 (4), 542-556, 2020 | 74 | 2020 |
| Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes J Bonneau, C Dumestre-Perard, M Rinaudo-Gaujous, C Genin, ... Autoimmunity reviews 14 (3), 231-245, 2015 | 73 | 2015 |
| Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity V Pavot, N Rochereau, J Rességuier, A Gutjahr, C Genin, G Tiraby, ... The Journal of Immunology 193 (12), 5781-5785, 2014 | 73 | 2014 |
| Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials A Carla-Moreau, S Paul, X Roblin, C Genin, L Peyrin-Biroulet Digestive and Liver Disease 47 (3), 191-196, 2015 | 67 | 2015 |
| Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy JC Antoine, N Boutahar, F Lassablière, E Reynaud, K Ferraud, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (12), 1347-1355, 2015 | 62 | 2015 |
| Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens JC Hernández, J Arteaga, S Paul, A Kumar, E Latz, S Urcuqui-Inchima AIDS research and human retroviruses 27 (10), 1099-1109, 2011 | 59 | 2011 |
| Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands V Pavot, N Climent, N Rochereau, F Garcia, C Genin, G Tiraby, ... Biomaterials 75, 327-339, 2016 | 52 | 2016 |
| Comparison of point-of-care and classical immunoassays for the monitoring infliximab and antibodies against infliximab in IBD Y Nasser, R Labetoulle, I Harzallah, AE Berger, X Roblin, S Paul Digestive Diseases and Sciences 63, 2714-2721, 2018 | 50 | 2018 |
